We've known since April that Facebook was searching for a new chief financial officer. Now, it has one: David Ebersman, formerly Genentech's finance chief. Roche acquired the biotech powerhouse in March.
There's no disputing Ebersman's pedigree, though there are good reasons to debate whether Facebook needed further financial expertise. Former CFO Gideon Yu previously served in senior positions at Google
Ebersman's resume isn't any better, really -- but he does have tenure. Ebersman was at Genentech for 15 years, and on Wall Street before that. He projects the image of a steady, experienced executive.
Most notably, as Facebook CEO Mark Zuckerberg pointed out in a statement, Ebersman also helped guide Genentech through its hypergrowth phase: "We quickly recognized that David was the right person for Facebook. He was Genentech's CFO while revenue tripled, and his success in scaling the finance organization of a fast growing company will be important to Facebook."
Translation: He's a trustworthy adult, and he knows how to work with us ambitious kids.
Bankers tend to smile favorably on firms that recruit experienced hands. Take Open Table
Ebersman could be to Facebook what Jordan was to Open Table: a welcome injection of operational expertise and a nod to the nervous IPO bankers at Goldman Sachs
Expect them to nod back. Today's Facebook looks more like a public company than at any other time in its history.
Get your clicks with related Foolishness:
Both our Stock Advisor and Inside Value services have recommended eBay and Disney to subscribers. Google is a Rule Breakers recommendation. Try any of our Foolish newsletter services free for 30 days.
Fool contributor Tim Beyers had stock and options positions in Google at the time of publication. Check out Tim's portfolio holdings and Foolish writings, or connect with him on Twitter as @milehighfool. The Motley Fool is also on Twitter as @TheMotleyFool. The Fool's disclosure policy is open 24 hours a day, seven days a week. Except for Flag Day, of course.